The oral direct thrombin inhibitor ximelagatran, and its subcutaneous form melagatran, compared with enoxaparin for prophylaxis of venous thromboembolism in total hip and total knee replacement: the EXPRESS study - Eriksson, BI; Agnelli, G; Cohen, AT (Pathophysiol Haemost Thromb, 2002)
abstr